Amgen Launches Rituxan Rival In US

As Company Reflects On Future Of Biosimilars In US

 
• By Akriti Seth
  
biosimilar_syringe
Amgen launches its third oncology biosimilar in the US market • Source: Shutterstock

More from Products

More from Generics Bulletin